Nicolas Méneveau

机构：Saint-Gobain (France), Institut Pasteur, Centre Hospitalier Universitaire de Besançon, Hôpital Privé Jean Mermo, A. O. Ordine Mauriziano di Torino, Observatoire des Sciences de l’Univers Terre Homme Environnement Temps Astronomie, Centre Hospitalier Universitaire de Saint-Étienne, French Clinical Research Infrastructure Network, Université de Franche-Comté · ORCID：0000-0002-1017-0463

发表论文 384 篇 · 总被引 27055 次 · h-index 55

代表论文

• Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial (2025 · The Lancet · 被引 84)
• 3-Year Clinical Outcomes Comparing the Amulet vs Watchman FLX for Left Atrial Appendage Closure in Patients With Atrial Fibrillation (2025 · Journal of the American College of Cardiology · 被引 13)
• The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry (2025 · Clinical Research in Cardiology · 被引 8)
• Modalities and safety of cardiac rehabilitation in a population managed for spontaneous haematoma or coronary disruption: insights from the READAPT-DISCO study (2025 · European Journal of Preventive Cardiology · 被引 5)
• Incidence and predictors of persistent left atrial appendage patency and its subtypes after percutaneous closure: a pre-specified analysis of the SWISS-APERO trial (2025 · European Heart Journal - Cardiovascular Imaging · 被引 4)
• Impact of a Clinical Valve Coordinator on Hospital Length of Stay and Patient Outcomes: Results From the BENCHMARK Registry (2025 · Structural Heart · 被引 3)